In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 104 for your search:
Drug:  vorinostat
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MK-0683-014, 2005_010, NCT00128102
2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-06-C-0040, MERCK-014-01, NCI-P6690, NCT00265577, UCLA-0506053-01, MERCK-014-00
3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MK-0683-088, 2008_525, NCT00773747
4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00093, IRB #NA 00001107, SKCCC J0570, NA 00001107, NCI-6884, JHOC-J0570, CDR0000467800, 6884, JHOC-00001107, J0570, U01CA070095, U01CA062491, NCT00324870
5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00095, 0511008257, NYWCCC-0511008257, CDR0000472916, NCI-6896, N01CM62204, 6896, NCT00324740
6.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03012, 06-05-291, N01CM62205, N01CM62209, N01CM62204, N01CM62207, AECM-0605291, NCI-7703, 7703, NCT00368875
7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-01050, 6898, N01CM62204, N01CM17103, NYCC-6898, NCI-6898, NCT00392353
8.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: BR05/24/06, DSRB Reference Code: B/06/275, HSA No: CTC0600314, NCT00416130
9.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: PSOC 2302, NCI-2010-00870, 6632, FHCRC-IR-6632, NCT00601718
10.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 60 and over
Sponsor: Other
Protocol IDs: 08-045, NCT00667615
11.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: PSHCI 08-005, NCT00702962
12.

Phase: Phase II, Phase I
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00672, N0874, U10CA025224, CDR0000609743, NCCTG-N0874, ABTC 0902, NCT00731731
13.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: GFM VOR 2007-01, NCT00776503
14.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0484, NCT00787527
15.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 50 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01147, 2288.00, IR-6921, CDR0000642213, R21CA139455, FHCRC-2288.00, 8297, NCT00895934
16.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Pro00016446, NCT00939991
17.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 09-114, NCT00948688
18.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2009-0651, NCT01110876
19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 2004_029, MK0683-013, NCT00097929
20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0412112-01, MERCK-CL-01-0303 (2), NCT00091559, MERCK-001-02
21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00099, PHL-040, CDR0000436851, N01CM62203, PMH-PHL-040, NCI-6916, 6916, NCT00121225
22.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0411065-01, MERCK-013-00, NCT00124631
23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03071, U10CA032102, S0517, CDR0000438779, SWOG-S0517, NCT00132028
24.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01468, 04110, N01CM71976, CDR0000439450, OSU-04110, 6902, NCI-6902, NCT00134043
25.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02667, GOG-0170H, U10CA027469, CDR0000439489, NCT00132067
1     
New Search